Overflow incontinence is most appropriately treated with which agent?

Prepare for the NBME Form 11 Test with targeted flashcards and multiple-choice questions. Each question includes hints and explanations to aid learning. Boost your readiness for exam day!

Multiple Choice

Overflow incontinence is most appropriately treated with which agent?

Explanation:
Overflow incontinence happens when the bladder can’t empty properly, so urine leaks as the bladder overfills. To address this, you want to boost detrusor (bladder muscle) contraction to improve emptying. Bethanechol is a muscarinic agonist that stimulates the detrusor to contract, promoting voiding and reducing retention, which directly treats the underlying problem of overflow. The other options don’t address detrusor contraction: tamsulosin helps relieve outlet obstruction by relaxing bladder neck/prostate but doesn’t fix an underactive detrusor; finasteride shrinks the prostate to reduce obstruction but isn’t an acute treatment for detrusor weakness; oxybutynin is an antimuscarinic that reduces bladder activity and would worsen overflow by impairing emptying.

Overflow incontinence happens when the bladder can’t empty properly, so urine leaks as the bladder overfills. To address this, you want to boost detrusor (bladder muscle) contraction to improve emptying. Bethanechol is a muscarinic agonist that stimulates the detrusor to contract, promoting voiding and reducing retention, which directly treats the underlying problem of overflow.

The other options don’t address detrusor contraction: tamsulosin helps relieve outlet obstruction by relaxing bladder neck/prostate but doesn’t fix an underactive detrusor; finasteride shrinks the prostate to reduce obstruction but isn’t an acute treatment for detrusor weakness; oxybutynin is an antimuscarinic that reduces bladder activity and would worsen overflow by impairing emptying.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy